Report Overview

Indian Hematology market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Hematology describes a branch of medicine, which deals with the study of blood and its diseases. It is a subspecialty of internal medicine and is concerned with nature, function, and blood diseases. Hematology uses highly developed technology to make specific diagnoses and treat illnesses occurring in all organ systems. Benign hematolgical disorders can be broadly divided into those with acquired and inherited causes. Acquired causes due to iron and vitamin deficiency indeed exceed the congenital causes. These are more common in women than in men. Women get iron deficiency more often due to excessive bleeding during menstruation and child birth. Worm infestation and piles contribute to iron deficiency anemia both among men and women. Occult malignancies which cause bleeding are also well-known causes for iron deficiency anemia. Nutritional deficiency, multiple pregnancies, and malabsorption contribute to dimorphic anemia - a combination of iron and folate/vitamin B₁₂deficiency.



Market Drivers

Blood disorders became a critical health issue in India, with different causes related to high mortality. Blood disorders, like anemia, blood cancer, hemorrhagic conditions, and blood infections, affect many people annually across all age groups. Increasing incidences of chronic diseases, geriatric population are accelerating the need of the market. The growing prevalence for point-of-care testing devices, improving support from the government through investments, people's interests in cost-effective diagnosis procedures are boosting the development of the market.